Loco-regional morbidity after breast conservation and axillary lymph node dissection for early breast cancer with or without regional nodes radiotherapy, perspectives in modern breast cancer treatment: the Skagen Trial 1 is active.
Identifieur interne : 000442 ( Main/Exploration ); précédent : 000441; suivant : 000443Loco-regional morbidity after breast conservation and axillary lymph node dissection for early breast cancer with or without regional nodes radiotherapy, perspectives in modern breast cancer treatment: the Skagen Trial 1 is active.
Auteurs : Hanne Melgaard Nielsen [Danemark] ; Rasmus Blechingberg Friis [Danemark] ; S Ren Linnet [Danemark] ; Birgitte Vrou Offersen [Danemark]Source :
- Acta oncologica (Stockholm, Sweden) [ 1651-226X ] ; 2017.
Abstract
Axillary lymph node dissection (ALND) and adjuvant radiotherapy (RT) in early breast cancer are associated with a risk of morbidity, including lymphedema and impaired shoulder mobility. The aim of this study was to evaluate loco-regional morbidity after breast conserving surgery (BCS), ALND, taxane-based chemotherapy and whole breast irradiation (WBI) with or without regional nodes RT.
DOI: 10.1080/0284186X.2016.1277261
PubMed: 28105873
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000410
- to stream PubMed, to step Curation: 000410
- to stream PubMed, to step Checkpoint: 000410
- to stream Ncbi, to step Merge: 008C36
- to stream Ncbi, to step Curation: 008C36
- to stream Ncbi, to step Checkpoint: 008C36
- to stream Main, to step Merge: 000442
- to stream Main, to step Curation: 000442
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Loco-regional morbidity after breast conservation and axillary lymph node dissection for early breast cancer with or without regional nodes radiotherapy, perspectives in modern breast cancer treatment: the Skagen Trial 1 is active.</title><author><name sortKey="Nielsen, Hanne Melgaard" sort="Nielsen, Hanne Melgaard" uniqKey="Nielsen H" first="Hanne Melgaard" last="Nielsen">Hanne Melgaard Nielsen</name><affiliation wicri:level="1"><nlm:affiliation>a Department of Oncology , Aarhus University Hospital , Aarhus , Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>a Department of Oncology , Aarhus University Hospital , Aarhus </wicri:regionArea><wicri:noRegion>Aarhus </wicri:noRegion></affiliation></author><author><name sortKey="Friis, Rasmus Blechingberg" sort="Friis, Rasmus Blechingberg" uniqKey="Friis R" first="Rasmus Blechingberg" last="Friis">Rasmus Blechingberg Friis</name><affiliation wicri:level="1"><nlm:affiliation>a Department of Oncology , Aarhus University Hospital , Aarhus , Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>a Department of Oncology , Aarhus University Hospital , Aarhus </wicri:regionArea><wicri:noRegion>Aarhus </wicri:noRegion></affiliation></author><author><name sortKey="Linnet, S Ren" sort="Linnet, S Ren" uniqKey="Linnet S" first="S Ren" last="Linnet">S Ren Linnet</name><affiliation wicri:level="1"><nlm:affiliation>b Department of Oncology , Herning Hospital , Herning , Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>b Department of Oncology , Herning Hospital , Herning </wicri:regionArea><wicri:noRegion>Herning </wicri:noRegion></affiliation></author><author><name sortKey="Offersen, Birgitte Vrou" sort="Offersen, Birgitte Vrou" uniqKey="Offersen B" first="Birgitte Vrou" last="Offersen">Birgitte Vrou Offersen</name><affiliation wicri:level="1"><nlm:affiliation>a Department of Oncology , Aarhus University Hospital , Aarhus , Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>a Department of Oncology , Aarhus University Hospital , Aarhus </wicri:regionArea><wicri:noRegion>Aarhus </wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28105873</idno><idno type="pmid">28105873</idno><idno type="doi">10.1080/0284186X.2016.1277261</idno><idno type="wicri:Area/PubMed/Corpus">000410</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000410</idno><idno type="wicri:Area/PubMed/Curation">000410</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000410</idno><idno type="wicri:Area/PubMed/Checkpoint">000410</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000410</idno><idno type="wicri:Area/Ncbi/Merge">008C36</idno><idno type="wicri:Area/Ncbi/Curation">008C36</idno><idno type="wicri:Area/Ncbi/Checkpoint">008C36</idno><idno type="wicri:Area/Main/Merge">000442</idno><idno type="wicri:Area/Main/Curation">000442</idno><idno type="wicri:Area/Main/Exploration">000442</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Loco-regional morbidity after breast conservation and axillary lymph node dissection for early breast cancer with or without regional nodes radiotherapy, perspectives in modern breast cancer treatment: the Skagen Trial 1 is active.</title><author><name sortKey="Nielsen, Hanne Melgaard" sort="Nielsen, Hanne Melgaard" uniqKey="Nielsen H" first="Hanne Melgaard" last="Nielsen">Hanne Melgaard Nielsen</name><affiliation wicri:level="1"><nlm:affiliation>a Department of Oncology , Aarhus University Hospital , Aarhus , Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>a Department of Oncology , Aarhus University Hospital , Aarhus </wicri:regionArea><wicri:noRegion>Aarhus </wicri:noRegion></affiliation></author><author><name sortKey="Friis, Rasmus Blechingberg" sort="Friis, Rasmus Blechingberg" uniqKey="Friis R" first="Rasmus Blechingberg" last="Friis">Rasmus Blechingberg Friis</name><affiliation wicri:level="1"><nlm:affiliation>a Department of Oncology , Aarhus University Hospital , Aarhus , Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>a Department of Oncology , Aarhus University Hospital , Aarhus </wicri:regionArea><wicri:noRegion>Aarhus </wicri:noRegion></affiliation></author><author><name sortKey="Linnet, S Ren" sort="Linnet, S Ren" uniqKey="Linnet S" first="S Ren" last="Linnet">S Ren Linnet</name><affiliation wicri:level="1"><nlm:affiliation>b Department of Oncology , Herning Hospital , Herning , Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>b Department of Oncology , Herning Hospital , Herning </wicri:regionArea><wicri:noRegion>Herning </wicri:noRegion></affiliation></author><author><name sortKey="Offersen, Birgitte Vrou" sort="Offersen, Birgitte Vrou" uniqKey="Offersen B" first="Birgitte Vrou" last="Offersen">Birgitte Vrou Offersen</name><affiliation wicri:level="1"><nlm:affiliation>a Department of Oncology , Aarhus University Hospital , Aarhus , Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>a Department of Oncology , Aarhus University Hospital , Aarhus </wicri:regionArea><wicri:noRegion>Aarhus </wicri:noRegion></affiliation></author></analytic><series><title level="j">Acta oncologica (Stockholm, Sweden)</title><idno type="eISSN">1651-226X</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Axillary lymph node dissection (ALND) and adjuvant radiotherapy (RT) in early breast cancer are associated with a risk of morbidity, including lymphedema and impaired shoulder mobility. The aim of this study was to evaluate loco-regional morbidity after breast conserving surgery (BCS), ALND, taxane-based chemotherapy and whole breast irradiation (WBI) with or without regional nodes RT.</div></front></TEI><affiliations><list><country><li>Danemark</li></country></list><tree><country name="Danemark"><noRegion><name sortKey="Nielsen, Hanne Melgaard" sort="Nielsen, Hanne Melgaard" uniqKey="Nielsen H" first="Hanne Melgaard" last="Nielsen">Hanne Melgaard Nielsen</name></noRegion><name sortKey="Friis, Rasmus Blechingberg" sort="Friis, Rasmus Blechingberg" uniqKey="Friis R" first="Rasmus Blechingberg" last="Friis">Rasmus Blechingberg Friis</name><name sortKey="Linnet, S Ren" sort="Linnet, S Ren" uniqKey="Linnet S" first="S Ren" last="Linnet">S Ren Linnet</name><name sortKey="Offersen, Birgitte Vrou" sort="Offersen, Birgitte Vrou" uniqKey="Offersen B" first="Birgitte Vrou" last="Offersen">Birgitte Vrou Offersen</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000442 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000442 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:28105873
|texte= Loco-regional morbidity after breast conservation and axillary lymph node dissection for early breast cancer with or without regional nodes radiotherapy, perspectives in modern breast cancer treatment: the Skagen Trial 1 is active.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:28105873" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |